These findings are sufficient to reveal the significant value of WTAP and MAP2K6 in the pathogenesis and prognosis of GC, provide ideas for the establishment of optimal diagnostic and prognostic biomarkers for GC patients, and have far-reaching guiding significance for the implementation of clinical medicine. The gene discussed is MAP2K6; the disease is gastric cancer.